Despite overwhelming evidence that vaccines are safe and effective, there has been a rise in vaccine hesitancy and refusal leading to increases in the incidence of communicable diseases. Importantly, providing scientific information about the benefits of vaccines has not been effective in counteracting anti-vaccination beliefs. Considering this, better identification of those likely to be vaccine hesitant and the underlying attitudes that predict these beliefs are needed to develop more effective strategies to combat anti-vaccination movements. Focusing on parents as the key decision makers in their children's vaccination, the aim of this study is to better understand the demographic and attitudinal predictors of parental vaccine hesitancy. We recruited 484 parents using Amazon MTurk and queried their attitudes on childhood vaccination, level of education, age, religiosity, political affiliation, trust in medicine, and disgust sensitivity. We found three main demographic predictors for parental vaccine hesitancy: younger age, lower levels of education, and greater religiosity. We also found vaccine hesitant parents to have significantly less trust in physicians and greater disgust sensitivity. These results provide a clearer picture of vaccine hesitant parents and suggest future directions for more targeted research and public health messaging.
Background
Ovarian removal via bilateral salpingo‐oophorectomy (BSO) prior to spontaneous menopause (SM) is related to increased Alzheimer’s disease (AD) risk (Rocca et al., 2007). Associative learning deficits are considered the earliest AD symptoms, heralding preclinical AD (Fowler et al., 2002). Performance and brain activation during a face‐name associative memory task differ based on reproductive stage and are linked to fluctuating levels of 17β‐estradiol (E2; Rentz et al., 2017). We hypothesized that BSO would affect memory and functional brain activity during associative encoding.
Method
Middle‐age women underwent functional magnetic resonance imaging (fMRI) while completing a face‐name associative memory task (Sperling et al., 2003). Recognition performance and brain activation during face‐name pair encoding were assessed in women with BSO taking E2‐based hormone therapy (BSO+E2; n=10; mean age=46), women with BSO taking no hormone therapy (BSO; n=12; mean age=49), age‐matched women with intact ovaries (AMC; n=14; mean age=44), and older women in spontaneous menopause (SM; n=15; mean age=56).
Result
No group differences in face‐name pair recognition accuracy were found. Multivariate partial least squares analyses (McIntosh & Lobaugh, 2004) revealed significant differences in brain‐behaviour correlations between BSO and SM groups. Accuracy in the SM group correlated positively with activation of the hippocampus, medial temporal, parietal, and frontal lobes, while accuracy in the BSO group correlated negatively with activation of these regions (see Figure). Region‐of‐interest (ROI) analyses revealed that functional activity in the right superior frontal lobe correlated positively with E2 levels in the BSO+E2 group (r=0.83, p=0.01), and negatively with E2 levels in the BSO group (r=‐0.66, p=0.03).
Conclusion
Activation of distinct brain regions underlying associative memory depends on E2 and age. The BSO group, who experienced menopause approximately 10 years earlier than the SM group, showed significantly different patterns of brain activation compared to the SM group, ultimately to achieve similar recognition accuracy. Importantly, there were no significant differences in performance, indicating that brain changes may precede associative memory changes, and that E2 depletion could play an important role in brain activity underlying women’s associative memory.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.